Author

Haijuan Du

Emory University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 2 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Approach:biophysical modeling· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

Andres Emanuelli CastaneriD· 2 shared Karen A. KirbyiD· 2 shared Peter D. KwongiD· 2 shared Stefan G. SarafianosiD· 2 shared William M. McFaddeniD· 2 shared Zachary C. LorsoniD· 2 shared Zhengqiang WangiD· 2 shared Adam S. OliaiD· 1 shared

Activity by Year

2023-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Andres Emanuelli CastanerORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals

Karen A. Kirby, William M. McFadden, Lin Wang, Haijuan Du, Huanchun Zhang, Andres Emanuelli Castaner, Zachary C. Lorson, Arvin Nafisi, Anastasia Selyutina, Charlotte Luchsinger, Atsuko Hachiya, Maria E. Cilento, Alexa A. Snyder, S Ravichandran, Xinyong Cai, , Stefan G. Sarafianos

The paper characterizes structural, biophysical, and virological properties of HIV-1 capsid-targeting antivirals, showing improved potency and stability through chemical modifications of PF74.

bioRxiv · Mar 25, 2026 · PreprintBiochemistry

Damaging the conical morphology of HIV-1 capsid by targeting the FG-binding pocket and disfavoring pentameric subunits needed for core closure

William M. McFadden, Karen A. Kirby, Zachary C. Lorson, Lei Wang, Carolyn M. Highland, Sophie R. Harvey, Savannah G. Brancato, Andres Emanuelli Castaner, Haijuan Du, Vicki Hopper Wysocki, Zhengqiang Wang, Robert A. Dick, Stefan G. Sarafianos

This study investigates how ZW-1261, an FGBP-targeting inhibitor, disrupts HIV-1 capsid morphology by affecting pentameric subunits and core closure.

bioRxiv · Mar 20, 2026 · PreprintMolecular Biology

Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus Macaques

Hongying Duan, Joseph P. Nkolola, Shuishu Wang, Jayeshbhai Chaudhari, I‐Ting Teng, Christy L. Lavine, Danealle K. Parchment, George S. Sellers, Krisha McKee, Sijy J. O'Dell, Misook Choe, Haijuan Du, Baoshan Zhang, Alejandro A. Espinosa Perez, Annika Rössler, , Dan H. Barouch

This study designs a dual-epitope vaccine targeting HIV-1 Env's fusion peptide and V2 apex, showing it elicits neutralizing antibodies against both sites in rhesus macaques.

Cell Reports · Jan 29, 2026Peer-reviewedImmunology

Tryptophan-like side chain holding aptamers inhibit respiratory syncytial virus infection of lung epithelial cells

Krisztina Percze, Zoltán János Tolnai, Marc J. Eleveld, Li Ou, Haijuan Du, Adam S. Olia, Peter D. Kwong, Marien Isaäk de Jonge, Tamás Mészáros

This study identifies aptamers that inhibit RSV infection by targeting the prefusion F protein, with modified nucleotides improving their stability and efficacy.

Scientific Reports · Jun 9, 2023Peer-reviewedMolecular Biology